Leimen, Germany

Drasko Brkovic

This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Drasko Brkovic: Innovator in Bladder Treatment

Introduction

Drasko Brkovic is a notable inventor based in Leimen, Germany. He has made significant contributions to the field of medical treatments, particularly concerning bladder health. His innovative approach has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Drasko Brkovic holds a patent for the "Use of diphosphonic acids or the physiologically acceptable salts or esters thereof in the preventive treatment of after-effects resulting from enlargement or replacement of the bladder." This invention focuses on the use of diphosphonic acids or compatible salts and esters for the preventive treatment of disturbances to ossary mineralization. These disturbances may occur after operative extension of the urine bladder by augmentation plasties or replacement of the urine bladder by replacement plasties, often manifesting years after the operation. He has 1 patent to his name.

Career Highlights

Drasko Brkovic is currently employed at Roche Diagnostics GmbH, where he continues to work on innovative solutions in the medical field. His expertise and dedication to improving patient outcomes have made him a valuable asset to the company.

Collaborations

One of his notable coworkers is Frieder Bauss, with whom he collaborates on various projects aimed at advancing medical technology and treatment options.

Conclusion

Drasko Brkovic's contributions to bladder treatment through his innovative patent demonstrate his commitment to enhancing medical care. His work at Roche Diagnostics GmbH continues to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…